Walder Wyss has advised SixPeaks Bio AG and its shareholders (including Versant Ventures). Lenz & Staehelin has advised AstraZeneca. AstraZeneca has completed the acquisition of Swiss...
AstraZeneca Acquires Swiss Biotech Firm SixPeaks Bio in USD 300 Million Deal
SixPeaks Bio AG’s $110 Million Series A Financing Round
Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...


























